does novo nordisk have a patent on semaglutide Whoops! novonordisk will lose its protection semaglutide, which is sold as #Ozempic and #Wegovy, in Canada after not paying nominal maintenance fee years before it became a blockbuster drug Semaglutide Patent Expires, Generic Versions
Pay in 4 interest-free payments of $5.88 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Live Spec
Semaglutide Patent Expires, Generic Versions Flood Market Anish Kumar Srivastava posted on the topic LinkedIn Novo's Ozempic Patent Expires Jan. 4 in Canada, But Generics Not Imminent Bloomberg New Delhi, March 19, 2026 On Friday, the key patent on semaglutidethe active molecule in Novo Nordisk's blockbuster drugs Ozempic and Wegovyexpired in India, marking a pivotal shift in the country's Ozempic's patent problem: how Novo Nordisk lost control of a blockbuster drug. Demand for GLP 1 weight loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite The patent for semaglutide the key ingredient in Ozempic and Wegovy developed by Novo Nordisk is set to expire in India on March 20, opening the door for a wave of low cost
Store: www.jokijarvenlomat.fi · Domain: www.jokijarvenlomat.fi

























